CT Financial Advisors’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

CT Financial Advisors’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$1.86K	Buy	+400	New	+$2.32K	﹤0.01%	563

Other funds holding SGYP

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

CT Financial Advisors's SGYP Position: Q1 2017 in Review

CT Financial Advisors opened a new position in Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2017: 400 shares worth $1.86K. The stake represents ﹤0.01% of the portfolio and ranks #563 among its holdings.

164 funds tracked by Wall St. Rank hold SGYP as of Q1 2017.

CT Financial Advisors held 400 shares of Synergy Pharmaceuticals, Inc Common Stock worth $1.86K as of Q1 2017.
Synergy Pharmaceuticals, Inc Common Stock was a new CT Financial Advisors position in Q1 2017.
Synergy Pharmaceuticals, Inc Common Stock made up ﹤0.01% of CT Financial Advisors's portfolio in Q1 2017, its #563 holding.
164 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2017.

Based on CT Financial Advisors's 13F filing for Q1 2017, filed 7 Apr 2017.